Regulatory

Lawmakers seek a policy of enforcement discretion but that wouldn’t address the underlying problem facing the hemp industry—namely FDA’s position that CBD cannot be marketed in a dietary supplement.

Former Food and Drug Administration Commissioner Scott Gottlieb lays out a pharma-friendly pathway for CBD in a Washington Post op-ed.

The new law is part of a growing movement driven by social enterprise and impact investors seeking out a new relationship to ownership.

The FDA hosted a day-long public meeting on “Responsible Innovation in Dietary Supplements." The meeting was highly anticipated as a sign of how open the FDA is to working with the supplements industry. Attendees offered different takeaways on...

Once thought to be the future of brick-and-mortar retail, cashless stores are now facing legal repercussions on the basis of economic discrimination.

AHPA, CHPA, CRN and UNPA join forces to advocate for consumer safety and access, industry growth and innovation.

While straw and plastic bag bans are becoming more and more common in cities nationwide, these three states are working to end plastic pollution on a much larger scale—here's how.

Over the last decade, state and federal lawmakers have increasingly embraced a plant that was long denounced: cannabis. FDA's challenge is figuring out whether and how to regulate cannabis-containing products--including dietary supplements that...

The agency is exercising "enforcement discretion," but not for companies making "over the line" claims.